Description
Ribociclib-[13C4,15N2] is an isotopic labelled Ribociclib, also known as LEE011, which is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity